Arrowhead Pharmaceuticals (ARWR) Current Deferred Revenue (2011 - 2026)
Arrowhead Pharmaceuticals (ARWR) reported Current Deferred Revenue of $94.6 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 311.7% from $22.98 million a year earlier but down 12.8% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Current Deferred Revenue (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals posted Current Deferred Revenue of $2.4 million.
- Current Deferred Revenue has a five-year compound annual growth rate of -34.1% (FY2020 to FY2025).
- By fiscal year, Current Deferred Revenue came in at $866,000 in FY2023 (-98.8%), $74.1 million in FY2022 (-33.3%) and $111.06 million in FY2021 (+475.7%).
- Five-year quarterly Current Deferred Revenue spans a low of $866,000 in fiscal Q4 2023 and a high of $111.93 million in fiscal Q1 2026.
- The high point for year-over-year Current Deferred Revenue in five years was fiscal Q4 2021 (growth of 475.7%); the low point was fiscal Q4 2023 (a decline of 98.8%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $108.54 million (Q2 2026), $111.93 million (Q1 2026) and $2.4 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Arrowhead Pharmaceuticals | 8.47 Bn | 3.24 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94.60 Mn |
| Mar 31, 2026 | 108.54 Mn |
| Dec 31, 2025 | 111.93 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 22.98 Mn |
| Mar 31, 2025 | 43.27 Mn |
| Sep 30, 2023 | 866,000.00 |
| Jun 30, 2023 | 16.91 Mn |
| Mar 31, 2023 | 29.84 Mn |
| Dec 31, 2022 | 66.28 Mn |
| Sep 30, 2022 | 74.10 Mn |
| Jun 30, 2022 | 84.29 Mn |
| Mar 31, 2022 | 97.87 Mn |
| Dec 31, 2021 | 108.65 Mn |
| Sep 30, 2021 | 111.06 Mn |
| Jun 30, 2021 | 150.93 Mn |
| Mar 31, 2021 | 144.88 Mn |
| Dec 31, 2020 | 6.74 Mn |
| Sep 30, 2020 | 19.29 Mn |
| Jun 30, 2020 | 26.27 Mn |
API Access
Arrowhead Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();